Market Expansion Sientra's recent launch of FDA-approved breast implant products in Canada indicates an opportunity to target international markets where the company aims to grow its presence in the aesthetic medical device sector.

Asset Reallocation The company's sale of key assets and closure of facilities suggest shifting strategic focuses, creating opportunities for sales of advanced surgical equipment, tissue expanders, and complementary technologies to support ongoing restructuring efforts.

Product Innovation Sientra's introduction of high-strength cohesive silicone gel implants presents a chance to engage with plastic surgeons seeking innovative, safe implant options, potentially expanding sales through product demonstration and education.

Industry Partnerships Strong partnerships with leading plastic surgeons and the company's focus on proprietary innovations highlight potential opportunities for collaborative product development, sales of surgical tools, and training services for high-end aesthetic procedures.

Growth through Acquisition The recent acquisition of a silicone scar treatment brand and asset sales indicate a strategic expansion into complementary aesthetic technologies, opening possibilities for cross-selling surgical and post-surgical care solutions to clinics and hospitals.